Frequency of apoptosis of tumor-infiltrating lymphocytes induced by Fas counterattack in human colorectal carcinoma and its correlation with prognosis

Clinical Cancer Research

Volumn 6, Issue 9, 2000, Pages 3560-3564

  Okada, K ^a   Komuta, K ^a   Hashimoto, S ^a   Matsuzaki, S ^a   Kanematsu, T ^a   Koji, T ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; LIGAND;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR ESCAPE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD95; APOPTOSIS; COLORECTAL NEOPLASMS; DNA FRAGMENTATION; FAS LIGAND PROTEIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROGNOSIS; STAINING AND LABELING;

EID: 0033812878     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. A genetic model for colorectal tumorigenesis
2. Genetic alterations in the adenoma-carcinoma sequence
3. Recent advances in molecular genetics of colorectal cancer
4. The APC gene product in normal and tumor cells
5. Cell-to-cell interaction in regulating diversity of neoplasms
6. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer
7. Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape
8. Fas ligand and immune evasion
9. Role of Fas ligand (CD95L) in immune escape: The tumor cell strikes back
10. Immune evasion by tumours: Involvement of the CD95 (APO-1/Fas) system and its clinical implications
11. T cell-tumor cell: A fatal interaction?
12. Fas/APO-1/CD95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia
13. Autonomous cell death of mouse male germ cells during fetal and postnatal period
14. Induction of apoptosis in ischemia-reperfusion model of mouse kidney: Possible involvement of Fas
15. Tumor expression of Fas ligand (CD95L) and the consequences
16. Expression of Fas(APO-1/CD95) in tumor-infiltrating and peripheral blood lymphocytes in patients with renal cell carcinoma
17. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - A mechanism of immune evasion?
18. The Fas counterattack in vivo: Apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma
19. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
20. Fas ligand expression in primary colon adenocarcinomas: Evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer
21. Differential staining of DNA strand breaks in dying cells by non-radioactive in situ nick translation
22. Nonradioactive in situ nick translation: A useful molecular histochemical tool to detect single-stranded DNA breaks
23. Frequency of apoptosis relates inversely to invasiveness and metastatic activity in human colorectal cancer
24. Immunohistochemical localization of Fas antigen in paraffin sections with rabbit antibodies against human synthetic Fas peptides
25. Human colon cancer cells express the functional Fas ligand
26. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas
27. The Fas counterattack: Cancer as a site of immune privilege
28. Antitumor effect of locally produced CD95 ligand
29. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction